Dividends & Buybacks ·
Jaguar Health effects one-for-fifteen reverse stock split to maintain Nasdaq listing compliance
JAGXJaguar Health, Inc.
Jaguar Health, Inc. effected a one-for-fifteen (15) reverse stock split of its common stock on September 17, 2026, to maintain compliance with Nasdaq listing standards. The company filed the Twelfth Amendment to its Certificate of Incorporation in Delaware on September 14, 2026, following shareholder approval at a special meeting held on April 20, 2026. Under the split, every fifteen shares were reclassified into one share without changing par value or authorized share count; fractional shares are cashed out. Outstanding options and warrants saw proportional reductions in share counts and increases in exercise prices. The company operates in the pharmaceutical industry, developing prescription drugs derived from plants for gastrointestinal diseases.